Aktie BGD BIOGENED S.A.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Biogened S.A.

Aktien

BGD

PLBIOGN00018

BGD

Schlusskurs Warsaw S.E.
Andere Börsenplätze
 00:00:00 16.05.2024 		% 5 Tage % 1. Jan.
22,4 PLN -2,61 % Intraday Chart für Biogened S.A. +1,82 % +24,44 %
14.02. Biogened S.A. meldet Ergebnis für das vierte Quartal und das Gesamtjahr bis zum 31. Dezember 2023 CI
2023 Biogened S.A. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Biogened S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Biogened S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Biogened S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
Biogened S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Biogened S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
Biogened S A : Raport kwartalny za II kwartał 2020 roku
Biogened S.A. Announces Dividend, Payable on November 11, 2020
Biogened S.A. Receives FDA Approval for Vumerity for Multiple Sclerosis
Biogened S.A. announced that it expects to receive PLN 0.5 million in funding
Biogened S.A. announced that it has received PLN 3 million in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. BGD Aktie
  4. Nachrichten Biogened S.A.
  5. Andere Sprachen